Results of ISMP's Survey on Drug Storage, Stability, Compatibility, and Beyond Use Dating

ISMP Medication Safety Alert 

In This Article

Conclusion

ISMP will be sharing the results of this study with CMS and The Joint Commission to help inform any future changes in the CMS policy that involves drug storage, stability, compatibility, and beyond use dating. It is understandable that CMS would rely on the expertise of FDA—the FDA-approved package inserts in this case—as the authorized source of information regarding US drugs. But since pharmacists can't rely on drug companies to continually test new parameters for drug storage, stability, and beyond use dating, or to quickly update the package insert to reflect new findings, they do rely on up-to-date compendia to inform best practices on these matters. We hope CMS finds the study results useful as they explore the issue of allowing pharmacists to incorporate newer evidence-based information about drug storage, stability, and beyond use dating into their practice settings.

Comments

3090D553-9492-4563-8681-AD288FA52ACE
Comments on Medscape are moderated and should be professional in tone and on topic. You must declare any conflicts of interest related to your comments and responses. Please see our Commenting Guide for further information. We reserve the right to remove posts at our sole discretion.
Post as:

processing....